COMMUNIQUÉS West-GlobeNewswire

Journée mondiale de l’alimentation : Québec doit reconnaître le droit à l’alimentation

16/10/2024 - 16:10

MONTRÉAL, 16 oct. 2024 (GLOBE NEWSWIRE) -- En cette Journée mondiale de l’alimentation, le Collectif Vital , qui réunit les appuis de 740 partenaires, souhaite joindre sa voix à la mobilisation pour la reconnaissance du [...]

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

16/10/2024 - 16:00

ST. LOUIS, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded arrangement with Rigel Pharmaceuticals, Inc , effective [...]

SCALE Healthcare Honors USOSM’s Richard Hall for Excellence

16/10/2024 - 15:41

IRVING, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) President and CEO Richard Hall recently received the SCALE Community MSO Excellence Award, which recognizes excellence in healthcare [...]

Renovaro Announces Strategic Restructuring and Leadership Transition

16/10/2024 - 15:28

Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full Five-Member Slate Realignment of Resources to Optimize and Commercialize RenovaroCube, the Company’ [...]

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

16/10/2024 - 15:20

During the Phase 1 study, subjects utilized EEG headsets provided by Firefly partner, Zeto, after which the data was analyzed using Firefly’s advanced AI BNA technology analysis platform TORONTO, Oct. 16, 2024 (GLOBE [...]

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

16/10/2024 - 15:15

HOUSTON, Oct. 16, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]

Cepham Prioritizes Women’s Health to Address Research and Innovation Gender Gap

16/10/2024 - 15:00

SOMERSET, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Cepham , a leader in nutraceutical research and development, is taking strategic steps to bridge the gender gap in health research and innovation, with a focus on women’ [...]

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

16/10/2024 - 15:00

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the [...]

Biomerica Reports First Quarter Fiscal 2025 Financial Results

16/10/2024 - 15:00

Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to 23%, Representing $1.0 to $1.4 Million Reduction Biomerica's At-Home PSA Screening [...]

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

16/10/2024 - 15:00

SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization [...]

LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024

15/10/2024 - 22:34

BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market [...]

Publication relating to transparency notifications

15/10/2024 - 22:30

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the [...]

Publication relative à des notifications de transparence

15/10/2024 - 22:30

INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 15 octobre 2024 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

15/10/2024 - 22:30

MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative [...]

Amwell announces new chief financial officer

15/10/2024 - 22:30

Industry veteran Mark Hirschhorn joins Amwell leadership team BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial [...]

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

15/10/2024 - 22:30

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after [...]

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15/10/2024 - 22:15

WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory [...]

Biodexa Announces Successful Appeal of Nasdaq Delisting

15/10/2024 - 22:15

Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company [...]

Sanofi: Information concerning the total number of voting rights and shares - September 2024

15/10/2024 - 22:05

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]